Prostate Cancer
Development of PARP inhibitors in advanced prostate cancer.
January 15, 2024
Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer.
January 15, 2024
Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3.
January 15, 2024
Temporal trends in cardiovascular burden among patients with prostate cancer receiving androgen deprivation therapy: a population-based cohort study.
January 12, 2024
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation.
January 12, 2024
Genomic classifiers and prognosis of localized prostate cancer: a systematic review.
January 12, 2024
Clinical Positron Emission Tomography/Computed Tomography: Quarter-Century Transformation of Prostate Cancer Molecular Imaging.
January 12, 2024
Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate Cancer.
January 11, 2024
Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?
January 11, 2024
Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer.
January 11, 2024
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer.
January 11, 2024
Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer.
January 11, 2024